Oura reaches $11 billion valuation with new $900 million fundraising
Oura announced Tuesday that it has raised over $900 million in a new Series E funding round, bringing the company’s value to $11 billion.
The fundraising campaign, led by Fidelity Management & Research Company, also includes new investor ICONIQ as well as contributions from Whale Rock and Atreides.
“With this investment, we will accelerate innovation, expand our global reach and set a new standard for what wearables can do to advance healthcare,” CEO Tom Hale said in a statement.
The Finnish company, ranked No. 23 on CNBC’s 2025 Disruptor 50 list, has raised about $1.5 billion, according to a press release.
The company, known for its Oura rings, competes with other smart ring manufacturers such as: Samsung and RingConn as well as fitness equipment from Whoop and Garmin.
Oura announced in September that it had sold over 5.5 million Oura Rings since launching in 2015, a significant increase from the 2.5 million rings announced in June 2024. The company reported revenue of over $500 million in 2024, more than doubling from last year, and expects to reach $1 billion in revenue this year.
To further expand in the wearable category, Oura has also expanded its features to compete with more general wearable devices like Apple or Samsung watches.
Along with its new Oura Ring 4 Ceramic, the company recently introduced Health Panels, a blood testing feature that allows users to schedule and view their lab results directly in the Oura app.
Users can track up to 50 biomarkers and receive their health data summary and diet or activity suggestions from Oura’s AI-powered advisor.
The ring maker also partnered with Dexcom, a leading provider of glucose monitoring technology, late last year to integrate Dexcom’s glucose data with biometric data collected by Oura to allow users to monitor their glucose levels.
“We are proud to create not just a product, but a global movement for proactive health – helping people understand their bodies, make better lifestyle choices and engage more effectively with their healthcare providers,” said Hale.
